We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$910M
AUM Growth
+$303M
(+50%)
Cap. Flow
+$298M
Cap. Flow
% of AUM
32.79%
Top 10 Holdings %
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXGXU
GX Acquisiton Corp. Unit
GXGXU
|
+$2.63M |
| 2 |
LCAHU
Landcadia Holdings II, Inc. Unit
LCAHU
|
+$2.3M |
| 3 |
HYACU
Haymaker Acquisition Corp. II Unit
HYACU
|
+$1.62M |
| 4 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.35M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.76% |
| 2 | Consumer Discretionary | 1.21% |
| 3 | Technology | 1% |
| 4 | Financials | 0.87% |
| 5 | Industrials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CALL
Greif
GEF
$4.56B
| $33K | ﹤0.01% |
+1,000
| New | +$37.2K |
|
1452
PENN Entertainment
PENN
$2.83B
| $33K | ﹤0.01% |
+1,700
| New | +$34.5K |
|
1453
CALL
Rayonier Advanced Materials
RYAM
$573M
| $33K | ﹤0.01% |
+5,100
| New | +$53.1K |
|
|
AVTA
1454
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
| $33K | ﹤0.01% |
+1,100
| New | +$36.2K |
|
|
NTUS
1455
CALL
DELISTED
Natus Medical Inc
NTUS
| $33K | ﹤0.01% |
+1,300
| New | +$33.1K |
|
1456
Galicia Financial Group
GGAL
$8.03B
| $32K | ﹤0.01% |
900
-2,800
| -76% | -$75.1K |
|
1457
Altria Group
MO
$122B
| $32K | ﹤0.01% |
670
| – | – |
|
1458
PUT
Ferrari
RACE
$66.8B
| $32K | ﹤0.01% |
+200
| New | +$28.8K |
|
|
SFIX
1459
PUT
Stitch Fix
SFIX
$536M
| $32K | ﹤0.01% |
+1,000
| New | +$26.8K |
|
|
TECD
1460
DELISTED
Tech Data Corp
TECD
| $32K | ﹤0.01% |
310
| – | – |
|
1461
PUT
Advance Auto Parts
AAP
$3.48B
| $31K | ﹤0.01% |
200
-6,100
| -97% | -$990K |
|
1462
Popular Inc
BPOP
$10.9B
| $31K | ﹤0.01% |
579
-789
| -58% | -$43.1K |
|
1463
PUT
Quest Diagnostics
DGX
$25.6B
| $31K | ﹤0.01% |
+300
| New | +$28.8K |
|
1464
Keysight
KEYS
$53.6B
| $31K | ﹤0.01% |
350
-1,650
| -83% | -$140K |
|
1465
Medifast
MED
$110M
| $31K | ﹤0.01% |
+240
| New | +$33.3K |
|
1466
CALL
NIO
NIO
$11.6B
| $31K | ﹤0.01% |
+12,100
| New | +$48.6K |
|
|
KRA
1467
DELISTED
Kraton Corporation
KRA
| $31K | ﹤0.01% |
+1,005
| New | +$30.4K |
|
|
ESV
1468
DELISTED
Ensco Rowan plc
ESV
| $31K | ﹤0.01% |
+3,632
| New | +$42K |
|
|
VISN
1469
PUT
Vistance Networks Inc
VISN
$2.67B
| $30K | ﹤0.01% |
+1,900
| New | +$38.6K |
|
1470
CALL
Crocs
CROX
$6.69B
| $30K | ﹤0.01% |
1,500
-7,400
| -83% | -$171K |
|
|
FOLD
1471
PUT
DELISTED
Amicus Therapeutics
FOLD
| $30K | ﹤0.01% |
2,400
-6,500
| -73% | -$82.5K |
|
1472
Herbalife
HLF
$1.26B
| $30K | ﹤0.01% |
690
-1,030
| -60% | -$48.8K |
|
|
AERI
1473
PUT
DELISTED
Aerie Pharmaceuticals
AERI
| $30K | ﹤0.01% |
+1,000
| New | +$38.5K |
|
1474
Hecla Mining
HL
$10.2B
| $29K | ﹤0.01% |
16,000
-3,000
| -16% | -$5.49K |
|
1475
PUT
Stanley Black & Decker
SWK
$14.6B
| $29K | ﹤0.01% |
+200
| New | +$28.2K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.
- Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
- Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
- Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
- Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
- Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
- Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
- Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.
Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.